References
- Jones R J. Biology and treatment of chronic myeloid leukemia. Current Opinion in Oncology 1997; 9: 3–7
- Gordon M Y. Cellular and molecular mechanisms in chronic myeloid leukemia: biology and treatment. British Journal of Haematology 1996; 95: 10–20
- Clarkson B D., Strife A., Wisniewski D., Lambek C., Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia 1997; 11: 1404–1428
- Mori N., Morosetti R., Lee S., Spira S., Ben-Yehuda D., Schiller G., Landolfi R., Mizoguchi H., Koeffler H P. Allotype analysis in the evolution of chronic myelocytic leukemia. Blood 1997b; 90: 2010–2014
- Tanaka K., Mansoor A M., Shigeta C., Nobuo Oguma, Kamada N. Lose of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. Cancer Genetics und Cytogenetics 1992; 61: 42–45
- Serra A., Guerrasio A., Gaidano G., Rosso C., Rege-Cambrin G., Petroni D., Mazza U., Saglio G. Molecular defects associated with acute phase CML. Leukemia and Lymphoma 1993; 11: 25–28
- Gaidano G., Serra A., Guerrasio A., Rege-Cambrin G., Mazza U., Saglio G. Genetic analysis of p53 and RB1 tumor suppressor genes in blast crisis of chronic myeloid leukemia. Annals of Hematology 1994; 68: 3–7
- Sill H., Goldman J M., Cross N CP. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 1995; 85: 2013–2016
- Ahuja H., Bar-Eli M., Arlin Z., Advani S., Allen S L., Goldman J., Snyder D., Foti A, Cline M. A spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. Journal of Clinical Investigation 1991; 87: 2042–2047
- Feinstein E., Cimino G., Gale R P., Alimena G., Berthier R., Kishi K., Goldman J., Zaccaria A., Berrebi A., Canaani E. p53 in chronic myelogenous leukemia in acute phase. Proceedings of the National Academy of Sciences USA 1991; 88: 6293–6297
- Marshal R., Shtalrid M., Talpaz M., Kantarjian H., Smith L., Beran M., Cork A., Trujillo J., Gutterman J., Deisseroth A. Rearrangement and expression of p53 in chronic phase and blast crisis of chronic myelogenous leukemia. Blood 1990; 75: 180–189
- Pabst T., Schwaller J., Bellomo M J., Oestreicher M., Mühlematter D., Tichelli A., Tobler A., Fey M F. Frequent clonal lose of heterozygosity and scarity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood 1996; 88: 1026–1034
- Parsons R., Li G-M., Longley M., Modrich P., Liu B., Berk T., Hamilton S R., Kizler K W., Vogelstein B. Mismatch repair deficiency in phenotypically normal human cells. Science 1995; 268: 738–740
- Bassam B J., Caetano-Anolles G., Gresshoff P M. Fast and sensitive silver staining of DNA in polyacrilamide gels. Anal Biochem. 1991; 196: 80–83
- Cross N CP. Microsatellite instability in myeloid leukemias. Blood 1994; 84: 3236
- Silly H., Chase A., Mills R I., Apfelbeck U., Sormann S., Goldman J M., Cross N CP. No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukemia blast crisis. Leukemia 1994; 8: 1923–1928
- Giesser H., Tkachuk D., Reis M D., Mak T N. Gene rearrangements and translocations in lymphopoliferative diseases. Blood 1989; 73: 1402–1415
- Pekarsky Y., Hallas C., Masaharu I., Russo G., Croce C M. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proceedings of the National Academy of Sciences USA 1999; 96: 2949–2951
- Hirata J., Takatsuki H., Umemura T., Goto T., Sadamura S., Abe Y., Nishimura J., Sato Nawata H. H. Recurrent appearance of 14q+ chromosome associated with lymphoid crisis of Ph-positive chronic myelogenous leukemia. Cancer Genetics and Cytogenetics 1993; 66: 103–107
- Palka G., Geraci L., Calabrese G., Stuppia L., Guanciali Franchi P., Parruti G., D'Antonio D., Fioritoni G. A new case of chronic myelogenous leukemia with 14q+ marker and review of the literature. Annals in Genetics 1988; 31: 190–192
- Mandalinski A., Drwinga H., Crilley P., Lasota J., Brodsky I., Croce C M., Nowell P C., Marks D I. Translocation (11, 14) in a newly diagnosed chronic myelogenous leukemia. Cancer Genetics and Cytogenetics 1995; 81: 24–27
- Spencer A., Szydlo R., Grand F H., Goldman J M., Melo J V. Abnormal patterns of immunglobulin heavy chain gene DNA fingerprinting during chronic phase chronic myeloid leukemia. Leukemia and Lymphoma 1999; 32: 299–307